1 / 7

Rubicon Research IPO Details Launch Date, Share Price, Size & Review

Intraday Trading also known as Day Trading is the one-day game in which you have to buy and sell or vice-versa on the same day before market close. Intraday trading is not easy, especially for inexperienced traders who find it difficult to select the right stocks or don't know where to enter into trade and exit timely.

moneysukh
Download Presentation

Rubicon Research IPO Details Launch Date, Share Price, Size & Review

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Rubicon Research IPO Details Launch Date, Share Price, Size & Review Rubicon Research Limited has been fastest growing Indian pharmaceuticals Formulations Company that focuses on innovation and research, with an increasing portfolio of specialty products and drug-device combination products targeting regulated markets, particularly the United States. In Fiscal 2024, among its 55 commercialized products, the company held a market share of more than 25% by volume for seven products. Read More www.moneysukh.com STOCK EQUITY IPO MUTUAL FUND FUTURE & OPTION ETF SGB EVENT TRACKER Market Hunt Derivative reports Commodity reports Margin updates Monthly Magazine Blogs

  2. The Main Objectives to Launch IPO As per the draft red hearing prospects, Rubicon Research Limited issue consists of both fresh issue and offer for sale by the promoter of the company. One of the main objectives of the company is to list on the bourses and also give the option to sell some of the stakes in the company. The offer for sale (OFS) consists of up to [●] equity shares aggregating up to ₹ 5,850 million. Nothing from those proceeds of OFS will be allotted to company Read More www.moneysukh.com STOCK EQUITY IPO MUTUAL FUND FUTURE & OPTION ETF SGB EVENT TRACKER Market Hunt Derivative reports Commodity reports Margin updates Monthly Magazine Blogs

  3. Rubicon Research Limited Financial Performance •Revenue from sales has almost doubled in FY24 to Rs. 8723 million from Rs. 4189 million in FY23. •Companies EBITDA margin has been increasing from -6.77% in FY22 to 19.84% in FY24 •Number of commercialized product in US has almost tripled from past two years from 18 in FY22 to 55 in FY24. Whereas, approved products in US has almost doubled to 69. Read More www.moneysukh.com STOCK EQUITY IPO MUTUAL FUND FUTURE & OPTION ETF SGB EVENT TRACKER Market Hunt Derivative reports Commodity reports Margin updates Monthly Magazine Blogs

  4. Competitive Strengths of the Company Fastest growing Indian pharmaceutical Co.: Companies revenue grew at a CAGR of 62.5% between FY22 to FY24, making us the fastest-growing Indian company among peers. Despite competition the company has managed to grown its market share in several products. Robust sales and distribution capabilities: As of FY24, the company marketed over 250 SKUs to 101 customers. The company has a strong marketing, sales, and distribution platform in the US through its subsidiary AdvaGen Pharma. Read More www.moneysukh.com STOCK EQUITY IPO MUTUAL FUND FUTURE & OPTION ETF SGB EVENT TRACKER Market Hunt Derivative reports Commodity reports Margin updates Monthly Magazine Blogs

  5. Risk Factors of the Company Concentration of clients: the company derived 65.14%, 62.99% and 92.44% of revenue in previous three years from top five customers. Any loss of business relation among top 5 clients can adversely affect business prospects and financials. History of losses: The Company has a history of incurring losses in previous financial years leading to negative EPS. Legal proceedings:The company and its director are involved in certain legal proceedings and any adverse decision in any of the proceedings may make the company liable to penalties. Read More www.moneysukh.com STOCK EQUITY IPO MUTUAL FUND FUTURE & OPTION ETF SGB EVENT TRACKER Market Hunt Derivative reports Commodity reports Margin updates Monthly Magazine Blogs

  6. Thank You Contact us: 96382-37000 Mansukh Securities and Finance Limited: SEBI Registration Number-INZ000164537 ( Members- NSE,BSE,MCX, ),IN-DP-72-2015 ( DP-NSDL, CDSL ) Mansukh Stock Brokers Limited : SEBI Registration Number- INZ000164937 ( Members -BSE ), IN-DP-36-2015 Mansukh Commodity Futures Private Limited : SEBI Registration Number-INZ000063032 ( Members- NCDEX ) Mansukh IFSC Broking Private Limited : SEBI Registration Number- INZ000099432 (Members- NSE IFSC, INDIA INX)Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances Investments in securities market are subject to market risks; read all the related documents carefully before investing. www.moneysukh.com STOCK EQUITY IPO MUTUAL FUND FUTURE & OPTION

  7. Related Resources • What Is Short Covering In Stock Market & How To Identify Rally? • Importance Of Volume In Technical Analysis: Use & Role In Trading • What Is Short Selling & How Does It Work: Is It Good Or Bad? • Trading or Investing Which is Better and More Profitable? • Best Algo Trading Platform and Trading Strategies • Best Intraday Algo Strategy • USD INR Options Trading Strategies • How to Read, Analyse & Use Candlestick Chart STOCK EQUITY IPO MUTUAL FUND FUTURE & OPTION ETF SGB EVENT TRACKER Market Hunt Derivative reports Commodity reports Margin updates Monthly Magazine Blogs

More Related